Spyre Therapeutics, Inc. (SYRE)
NASDAQ: SYRE · Real-Time Price · USD
16.26
+0.23 (1.47%)
Oct 8, 2025, 9:56 AM EDT - Market open

Spyre Therapeutics Stock Forecast

Stock Price Forecast

The 5 analysts that cover Spyre Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $57.6, which forecasts a 254.35% increase in the stock price over the next year. The lowest target is $43 and the highest is $70.

Price Target: $57.6 (+254.35%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$43$57.6$65$70
Change+164.53%+254.35%+299.88%+330.64%

Analyst Ratings

The average analyst rating for Spyre Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingMay '25Jun '25Jul '25Aug '25Sep '25Oct '25
Strong Buy222233
Buy555522
Hold111111
Sell000000
Strong Sell000000
Total888866

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Deutsche Bank
Deutsche Bank
Strong Buy
Initiates
$43
Strong BuyInitiates$43+164.53%Sep 26, 2025
BTIG
BTIG
Strong Buy
Reiterates
$70
Strong BuyReiterates$70+330.64%Sep 16, 2025
Leerink Partners
Leerink Partners
Buy
Initiates
$45
BuyInitiates$45+176.84%Apr 8, 2025
Jones Trading
Jones Trading
Hold
Initiates
n/a
HoldInitiatesn/an/aDec 11, 2024
Baird
Baird
Buy
Maintains
$50$65
BuyMaintains$50$65+299.88%Nov 13, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.93
from -3.18
EPS Next Year
-3.36
from -2.93
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
-18.74M2.33M886.00K---
Revenue Growth
---87.57%-61.96%---
EPS
-37.89-25.02-24.86-13.76-3.18-2.93-3.36
EPS Growth
-------
Forward PE
-------
No. Analysts
-----1413
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
Highn/an/a
Avgn/an/a
Lown/an/a

Revenue Growth

Revenue Growth20252026202720282029
High--
Avg--
Low--

EPS Forecast

EPS20252026202720282029
High-2.42-2.61
Avg-2.93-3.36
Low-3.43-4.12

EPS Growth

EPS Growth20252026202720282029
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.